clinical trial

Diabetic eye diseases are the leading cause of blindness in the working age populationVX-01 is an oral therapy – current treatments require regular invasive intravitreal injections and…

The Phase 3 clinical trial of cytisinicline, conducted on a large scale and led by a Massachusetts General Hospital (MGH) investigator, demonstrates the medication's efficacy and high…

Phoenix, AZ, July 18, 2023 (GLOBE NEWSWIRE) -- In an effort to discover new treatments for brain tumors, such as glioblastoma, the Ivy Brain Tumor Center at Barrow Neurological Institute,…

Chicago, July 07, 2023 (GLOBE NEWSWIRE) -- The clinical trials industry is on the cusp of transformative advancements in the near future. With ongoing advancements in technology, data…

PRINCETON, N.J., July 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery…

DALLAS, TX and MANHASSET, NY, July 06, 2023 (GLOBE NEWSWIRE) --  Five Liters, a Dallas-based wearable neuromodulation company, is embarking on a series of groundbreaking first-in-human…

Approval from FDA to initiate Phase II trial with LSALT peptide to target cardiac surgery-associated acute kidney injury (CS-AKI)LSALT peptide targets dipeptidase-1 (DPEP-1), an enzyme…

MINNEAPOLIS, June 22, 2023 (GLOBE NEWSWIRE) -- Results of a Phase III randomized clinical trial published in the New England Journal of Medicine indicates that a new strategy for…

ORLANDO, Fla., June 13, 2023 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced medical clinics in the world, is sharing the results of a new study that shows that a unique…

MONTRÉAL, 12 juin 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur le…